ALLO Insider Buying
The table below summarizes the most recent ALLO insider buying information — the latest buy being $4,999,997.30 by Arie Belldegrun on 5/16/2024, with links to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall Street, there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why ALLO insider buys like these are important for investors to follow.
| Date | Insider | Price | Amount |
|---|---|---|---|
| 5-16-2024 Insider Buy |
Arie Belldegrun Director |
$2.90 CAGR » |
$4,999,997.30 1,724,137 shares |
| 1-30-2024 Insider Buy |
Geoffrey M. Parker CHIEF FINANCIAL OFFICER |
$3.59 CAGR » |
$683.05 190 shares |
| 1-12-2022 Insider Buy |
Joshua A. Kazam |
$12.60 CAGR » |
$189,000.00 15,000 shares |
| 10-15-2018 Insider Buy |
Arie Belldegrun Director |
$18.00 CAGR » |
$3,500,010.00 194,445 shares |
| 10-15-2018 Insider Buy |
Inc Pfizer >10% Owner |
$18.00 CAGR » |
$1,000,008.00 55,556 shares |
| 10-15-2018 Insider Buy |
Franz B. Humer Director |
$18.00 CAGR » |
$540,000.00 30,000 shares |
| 10-15-2018 Insider Buy |
Owen N. Witte Director |
$18.00 CAGR » |
$270,000.00 15,000 shares |
| 10-15-2018 Insider Buy |
TPG Group Holdings (SBS) Advisors, Inc. >10% Owner |
$18.00 CAGR » |
$12,150,000.00 675,000 shares |
Also See: SEC filings
Allogene Therapeutics Insider Purchase CAGR Analysis
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 05/17/2024 | |
| End date: | 07/15/2026 | |
| Start price/share: | $2.77 | |
| End price/share: | $1.90 | |
| Dividends collected/share: | $0.00 | |
| Total return: | -31.41% | |
| Average Annual Total Return: | -16.00% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $6,859.92 | |
| Years: | 2.16 | |
